In last trading session, CervoMed Inc (NASDAQ:CRVO) saw 0.74 million shares changing hands with its beta currently measuring -0.73. Company’s recent per share price level of $6.05 trading at -$1.06 or -14.85% at ring of the bell on the day assigns it a market valuation of $52.65M. That closing price of CRVO’s stock is at a discount of -240.99% from its 52-week high price of $20.63 and is indicating a premium of 70.25% from its 52-week low price of $1.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.16 million shares which gives us an average trading volume of 437.99K if we extend that period to 3-months.
For CervoMed Inc (CRVO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
CervoMed Inc (NASDAQ:CRVO) trade information
Upright in the red during last session for losing -14.85%, in the last five days CRVO remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $6.05 price level, adding 15.97% to its value on the day. CervoMed Inc’s shares saw a change of -69.75% in year-to-date performance and have moved -11.68% in past 5-day. CervoMed Inc (NASDAQ:CRVO) showed a performance of -23.13% in past 30-days. Number of shares sold short was 0.27 million shares which calculate 1.79 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 16.32 to the stock, which implies a rise of 62.93% to its current value. Analysts have been projecting 16.32 as a low price target for the stock while placing it at a high target of 19.29. It follows that stock’s current price would drop -169.75% in reaching the projected high whereas dropping to the targeted low would mean a loss of -169.75% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 56.66% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 0.77% while estimates for its earnings growth in next 5 years are of 4.31%.
CervoMed Inc (NASDAQ:CRVO)’s Major holders
Insiders are in possession of 33.38% of company’s total shares while institution are holding 26.31 percent of that, with stock having share float percentage of 39.50%. Investors also watch the number of corporate investors in a company very closely, which is 26.31% institutions for CervoMed Inc that are currently holding shares of the company. RA CAPITAL MANAGEMENT, L.P. is the top institutional holder at CRVO for having 0.82 million shares of worth $13.99 million. And as of 2024-06-30, it was holding 9.3892 of the company’s outstanding shares.
The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 0.64 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.354 of outstanding shares, having a total worth of $10.96 million.
